Madison, CT, United States of America

Jason Allan Wiles

This inventor holds 82 USPTO granted patents and 28 published patent applications, plus 2 CIPO patents and 20 EPO patents, primarily in Pharmaceutical Compounds (CPC class C07D401-14). Top assignees: Achillion Pharmaceuticals, Inc., Avilar Therapeutics, Inc.. Active years: 2007-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason Allan Wiles. Retrieved from https://idiyas.com/inventor/jason-allan-wiles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 82 

% Patents Active = 79.3

 

 

Average Co-Inventor Count = 7.3

ph-index = 22

Forward Citations = 943(Granted Patents)

Forward Citations (Not Self Cited) = 171(Dec 10, 2025)


Inventors with similar research interests:

🔬 See more inventors

Location History:

  • Hamden, CT (US) (2007 - 2018)
  • Madison, CT (US) (2014 - 2024)

Company Filing History:


Years Active: 2007-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pharmaceutical Compounds
ASGPR-Binding
Macrocyclic Compounds
Heteroaryl Compounds
Immune Disorders
Inflammatory Disorders
Complement Mediated Disorders
Amino Compounds
Quinazoline Compounds
Indole Compounds
Amide Compounds
Disubstituted Compounds
82 patents (USPTO):Explore Patents

Title: The Innovative World of Jason Allan Wiles

Introduction:

Jason Allan Wiles, a prolific inventor hailing from Madison, CT, has left a remarkable impact in the field of research and development with an impressive portfolio of 67 patents.

Latest Patents:

His recent patents showcase groundbreaking advancements in the treatment of immune and inflammatory disorders. Specifically, Wiles has pioneered the development of aryl, heteroaryl, and heterocyclic compounds targeting Factor D to regulate the complement cascade and reduce excessive complement activation. Moreover, his work includes ASGPR-binding compounds designed for the selective degradation of extracellular proteins to address various disorders mediated by these proteins.

Career Highlights:

Wiles' innovative spirit has been instrumental in his tenure at leading pharmaceutical companies such as Achillion Pharmaceuticals, Inc. His contributions have been integral to the growth and success of the companies, solidifying his reputation as a visionary in the healthcare industry.

Collaborations:

Throughout his career, Wiles has collaborated with esteemed professionals in the field, including notable coworkers like Milind Deshpande and Avinash S Phadke. Together, they have pushed the boundaries of science and paved the way for transformative medical solutions.

Conclusion:

In conclusion, Jason Allan Wiles stands as a shining example of ingenuity and dedication in the world of innovation. His pioneering work continues to make a significant impact on the field of medicine, offering hope for improved treatments and better healthcare outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…